Literature DB >> 16344924

Rosiglitazone-associated pseudotumour cerebri.

S Dagdelen, O Gedik.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16344924     DOI: 10.1007/s00125-005-0055-9

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  4 in total

Review 1.  Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association.

Authors:  Richard W Nesto; David Bell; Robert O Bonow; Vivian Fonseca; Scott M Grundy; Edward S Horton; Martin Le Winter; Daniel Porte; Clay F Semenkovich; Sidney Smith; Lawrence H Young; Richard Kahn
Journal:  Diabetes Care       Date:  2004-01       Impact factor: 19.112

2.  Peroxisome proliferator-activated receptor-gamma ligands inhibit choroidal neovascularization.

Authors:  T Murata; S He; M Hangai; T Ishibashi; X P Xi; S Kim; W A Hsueh; S J Ryan; R E Law; D R Hinton
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-07       Impact factor: 4.799

3.  Response of experimental retinal neovascularization to thiazolidinediones.

Authors:  T Murata; Y Hata; T Ishibashi; S Kim; W A Hsueh; R E Law; D R Hinton
Journal:  Arch Ophthalmol       Date:  2001-05

4.  Differential diagnosis of patients with intracranial sinus venous thrombosis related isolated intracranial hypertension from those with idiopathic intracranial hypertension.

Authors:  P N Sylaja; N V Ahsan Moosa; K Radhakrishnan; P Sankara Sarma; S Pradeep Kumar
Journal:  J Neurol Sci       Date:  2003-11-15       Impact factor: 3.181

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.